Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Ribavirin Pregnancy Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by INC Research
Sponsor:
Collaborators:
Aurobindo Pharma USA
Genentech, a member of the Roche Group
Sandoz Pharmaceuticals Inc.
Merck Sharp & Dohme Corporation, a subsidiary of Merck & Co., Inc.
Teva Pharmaceuticals USA
Kadmon Pharmaceuticals, LLC
Zydus Pharmaceuticals USA, Inc.
Information provided by (Responsible Party):
INC Research
ClinicalTrials.gov Identifier:
NCT00114712
First received: June 16, 2005
Last updated: December 5, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: No date given